1,5-dibromo-2,3-dichlorobenzene

Catalog No.: 
ACIWBE172
CAS No.: 
81067-42-7
Molecular Formula: 
C6H2Br2Cl2
Molecular Weight: 
301.79
1,5-dibromo-2,3-dichlorobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$59.00In stockIn stock
5g95%$204.00In stockIn stock
25g95%$714.00In stockIn stock
100g95%$2736.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,5-dibromo-2,3-dichlorobenzene
IUPAC Name1,5-dibromo-2,3-dichlorobenzene
MDL No.MFCD00070783
Molecular FormulaC6H2Br2Cl2
Molecular Weight301.79
SMILESClC1=C(Cl)C(Br)=CC(Br)=C1
InChI KeySRGMUFKQUPKYQW-UHFFFAOYSA-N
Synonym3,5-DIBROMO-1,2-DICHLOROBENZENE;1,5-dibromo-2,3-dichlorobenzene;Benzene, 1,5-dibromo-2,3-dichloro-;1,5-Dibromo-2,3-dichlorobenzene - [D94594]
CAS No.81067-42-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIWBE172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. ACDJZR623 route compound structure diagram
    ACDJZR623202925-04-0In Stock
  4. Then
  5. ACIWBE172 route product structure diagram
    ACIWBE17281067-42-7In Stock
Inquiry

2. ACIWBE172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWBE172 route product structure diagram
    ACIWBE17281067-42-7In Stock
Inquiry

3. ACIWBE172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIWBE172 route product structure diagram
    ACIWBE17281067-42-7In Stock
Inquiry

Comments (0)